Related Experiment Video
Updated: Feb 23, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in
Chuiguo Huang1, Naijun Yuan2, Liying Wu3
1Department of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou.
Abstract:
Papillary renal cell carcinoma (PRCC) is the second most common subtype of renal cell carcinoma, and it lacks effective therapeutic targets and prognostic molecular biomarkers. Attention has been increasingly focused on long noncoding RNAs (lncRNAs), which can act as competing endogenous RNA (ceRNA) to compete for shared microRNAs (miRNAs) in the tumorigenesis of human tumors. Therefore, to clarify the functional roles of lncRNAs with respect to the mediated ceRNA network in PRCC, we comprehensively integrated expression profiles, including data on mRNAs, lncRNAs and miRNAs obtained from 289 PRCC tissues and 32 normal tissues in The Cancer Genome Atlas. As a result, we identified 2,197 differentially expressed mRNAs (DEmRNAs) and 84 differentially expressed miRNAs (DEmiRNAs) using a threshold of |log2 (fold change)| >2.0 and an adjusted P-value <0.05. To determine the hub DEmRNAs that could be key target genes, a weighted gene co-expression network analysis was performed. A total of 28 hub DEmRNAs were identified as potential target genes. Seven dysregulated DEmiRNAs were identified that were significantly associated with the 28 hub potential target genes. In addition, we found that 16 differentially expressed lncRNAs were able to interact with the DEmiRNAs. Finally, we used Cytoscape software to visualize the ceRNA network with these differently expressed molecules. From these results, we believe that the identified ceRNA network plays a crucial role in the process of PRCC deterioration, and some of the identified genes are strongly related to clinical prognosis.
Insights
This study reveals a crucial competing endogenous RNA (ceRNA) network involving long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) in papillary renal cell carcinoma (PRCC) progression. The findings offer potential molecular biomarkers for PRCC diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Papillary renal cell carcinoma (PRCC) lacks effective therapeutic targets and prognostic biomarkers.
- Long noncoding RNAs (lncRNAs) are implicated in tumorigenesis via competing endogenous RNA (ceRNA) networks.
- Understanding the lncRNA-mediated ceRNA network in PRCC is critical for identifying novel therapeutic strategies.
Purpose of the Study:
- To elucidate the functional roles of lncRNAs in the ceRNA network within PRCC.
- To identify key differentially expressed molecules (mRNAs, lncRNAs, miRNAs) involved in PRCC pathogenesis.
- To construct and visualize the PRCC-specific ceRNA network.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) data for 289 PRCC and 32 normal tissues.
- Performed differential expression analysis for mRNAs, lncRNAs, and miRNAs.
- Employed weighted gene co-expression network analysis (WGCNA) to identify hub genes.
- Constructed the ceRNA network using Cytoscape software.
Main Results:
- Identified 2,197 differentially expressed mRNAs (DEmRNAs) and 84 differentially expressed miRNAs (DEmiRNAs).
- Discovered 28 hub DEmRNAs as potential key target genes.
- Found 7 dysregulated DEmiRNAs significantly associated with hub DEmRNAs.
- Identified 16 differentially expressed lncRNAs interacting with DEmiRNAs, forming a PRCC ceRNA network.
Conclusions:
- The constructed ceRNA network plays a significant role in PRCC progression.
- Specific genes within this network show strong correlations with clinical prognosis.
- These findings provide potential molecular biomarkers for PRCC diagnosis and targeted therapy.
More Related Videos
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs